Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors

Future Oncology, Ahead of Print.

Source: Future Oncology - January 12, 2024 Category: Cancer & Oncology Authors: Changhoon Yoo Angela Lamarca Hye Jin Choi Arndt Vogel Michael J Pishvaian Lipika Goyal Makoto Ueno Angela M ärten Michael Teufel Lijiang Geng Chigusa Morizane Source Type: research